Vesico-Ureteral Reflux Clinical Trial
Official title:
Clinical Applications of Contrast-Enhanced Ultrasonography in Pediatric Population - Intravesicle Administration
In children, specifically the intravesicle administration to study vesicoureteral reflux in children already catheterized and scheduled for voiding cystourethrogram (VCUG). Contrast-enhanced ultrasonography is a tremendous advancement from conventional B-mode and color Doppler ultrasonography, as it permits noninvasive, non-ionizing delineation of physiology and pathophysiology with higher resolution and accuracy in children. The technique is particularly useful in pediatric population whose lifetime risk of cancer significantly increases with higher frequency of ionizing radiation. Voiding cystourethrogram is a fluoroscopy technique that can study reflux real time but at the risk of radiation side effects. In this regard, intravesicle administration of ultrasound contrast agent can help avoid radiation in children and potentially replace the conventionally used voiding cystourethrogram.
The most commonly used genitourinary application of ultrasound contrast agent is for the
diagnosis of vesicoureteral reflux via intra-vesicle administration of contrast agent. The
utility of ultrasound contrast agent in contrast-enhanced voiding urosonography is well
established and published over two decades (Darge 2002, Darge 2008, Darge 2010). As with
other applications of ultrasound contrast agents, the method offers the advantages of no
radiation, low cost, excellent anatomic detail, and higher sensitivity for reflux detection
than VCUG. The most comprehensive study to detail the safety profile of intravesicle
ultrasound contrast is by Papadopoulou et al. (Papadopoulou, Ntoulia et al. 2014) which
described a total of 1,010 children (563 girls, 447 boys) with a mean age of 2.9 years. No
adverse events were reported at 1 hour after exam. Follow-up phone interviews revealed no
adverse events in the majority (973 of 1,010). The remaining 37 children experienced mild
symptoms including dysuria (n=26) and urinary retention (n=2) which may have been related to
catheterization rather than the contrast agent. A recent European survey at 29 centers
evaluating the use of ultrasound contrast agent in 4,131 children for pediatric reflux
diagnosis reported no adverse events (Riccabona 2012).
The procedure consists of pre-contrast, post-contrast, voiding phase, and post-void depiction
of the kidneys, ureters, bladder, and transperineal scan of the urethra, for identification
of potential ectopic ureters (Darge 2008, Duran, del Riego et al. 2012) that can easily be
missed on non-distended ureters on CT, MRI, or radionuclide imaging. The two primary methods
of contrast injection includes direct injection into a partially filled bladder (Darge 2008)
and another using a saline bag for subsequent drip infusion via the catheter into the bladder
(Back, Edgar et al. 2015).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02271035 -
A Prospective Study Comparing the Success Rate of Injection of (DefluxR) Versus (VantrisR) for VUR in Children
|
Phase 4 | |
Not yet recruiting |
NCT03653702 -
Radiation-Free Technique for Evaluating Renal Scarring (RAFTERS)
|
Phase 1 | |
Completed |
NCT04798443 -
Endoscopic Injection of Dextranomer/Hyaluronic Acid Versus Ureteral Reimplantation In Treatment of Vesicoureteral Reflux
|
N/A | |
Completed |
NCT05864131 -
Effects of Parental Holding on Pain Response in Young Children During Cystometry
|
N/A | |
Completed |
NCT02204917 -
CeVUS With Intravesical Administration of OPTISON TM (Trademark) in Children
|
Phase 1/Phase 2 | |
Completed |
NCT01297673 -
Reflux in Spinal Cord Injury Patients With Neurogenic Lower Urinary Tract Dysfunction
|
N/A | |
Recruiting |
NCT00367159 -
Evaluation of the Efficiency of Autologous Adipocytes Graft in Endoscopic Treatment in Vesico-Renal Reflux in Children
|
Phase 3 | |
Active, not recruiting |
NCT04251988 -
VR to Reduce Pain and Anxiety During GU Scans
|
N/A |